Published in J Thorac Oncol on July 01, 2006
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol (2012) 1.52
The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) (2012) 1.49
Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.35
Technical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.25
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Res (2011) 1.20
Mucins in pancreatic cancer and its microenvironment. Nat Rev Gastroenterol Hepatol (2013) 1.17
Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res (2008) 1.13
Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta (2009) 1.03
Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma. Am J Gastroenterol (2013) 0.99
Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer. Br J Cancer (2012) 0.96
Applications of protein microarrays for biomarker discovery. Proteomics Clin Appl (2008) 0.96
Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer (2010) 0.94
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Br J Cancer (2013) 0.92
Development of a multiplex autoantibody test for detection of lung cancer. PLoS One (2014) 0.91
Identification of lung cancer with high sensitivity and specificity by blood testing. Respir Res (2010) 0.91
Identification of Hnrph3 as an autoantigen for acute anterior uveitis. Clin Immunol (2010) 0.91
Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis. Biochem Biophys Res Commun (2012) 0.90
Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer. Cancer Biol Ther (2010) 0.89
Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc (2011) 0.87
Improving seroreactivity-based detection of glioma. Neoplasia (2009) 0.86
Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts. PLoS One (2014) 0.86
Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol (2015) 0.86
Early lung cancer diagnosis by biosensors. Int J Mol Sci (2013) 0.84
Serologic laboratory findings in malignancy. Rheum Dis Clin North Am (2011) 0.83
Serum autoantibody measurement for the detection of hepatocellular carcinoma. PLoS One (2014) 0.83
Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab (2009) 0.82
Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. J Transl Med (2015) 0.82
Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? J Cancer Res Clin Oncol (2012) 0.82
Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma. Oncol Lett (2014) 0.81
Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries. Mol Cell Proteomics (2011) 0.81
Antibody profiling with protein antigen microarrays in early stage cancer. Expert Opin Med Diagn (2012) 0.79
Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay. J Immunol Methods (2009) 0.79
Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer. Oncol Rep (2016) 0.78
Biomarkers of risk to develop lung cancer in the new screening era. Ann Transl Med (2016) 0.78
Autoantibodies against p53 are associated with chromosome 17p deletions in chronic lymphocytic leukemia. Leuk Res (2011) 0.78
A novel autoantibody test for the detection of pre-neoplastic lung lesions. Mol Cancer (2014) 0.78
Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer. Onco Targets Ther (2013) 0.77
Identification of novel autoantibodies for detection of malignant mesothelioma. PLoS One (2013) 0.77
Early detection of NSCLC with scFv selected against IgM autoantibody. PLoS One (2013) 0.76
Usage of cancer associated autoantibodies in the detection of disease. Cancer Biomark (2010) 0.76
Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma. Dis Markers (2013) 0.76
Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis. Int J Clin Exp Pathol (2015) 0.75
A panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. Cancer Sci (2017) 0.75
Peptides from the variable region of specific antibodies are shared among lung cancer patients. PLoS One (2014) 0.75
Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. PLoS One (2017) 0.75
Progress and prospects of early detection in lung cancer. Open Biol (2017) 0.75
The biomarker landscape in mycosis fungoides and sézary syndrome. Exp Dermatol (2016) 0.75
BARD1 serum autoantibodies for the detection of lung cancer. PLoS One (2017) 0.75
Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer. Onco Targets Ther (2017) 0.75
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Computed tomography screening and lung cancer outcomes. JAMA (2007) 8.01
Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med (2002) 5.10
Lung cancer screening with CT: Mayo Clinic experience. Radiology (2003) 4.72
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg (2012) 4.68
CT screening for lung cancer: five-year prospective experience. Radiology (2005) 4.33
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci (2008) 4.28
Non-small-cell lung cancer. Lancet (2011) 3.45
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology (2007) 3.44
Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest (2010) 3.13
Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations. J Thorac Oncol (2012) 3.10
Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics (2003) 2.52
5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest (2009) 2.45
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol (2003) 2.32
Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol (2004) 2.18
Advances in chemotherapy of non-small cell lung cancer. Chest (2006) 2.00
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol (2006) 1.85
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.81
Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg (2004) 1.77
Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol (2010) 1.71
Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg (2004) 1.67
Global identification of targets of the Arabidopsis MADS domain protein AGAMOUS-Like15. Plant Cell (2009) 1.63
A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest (2006) 1.59
Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol (2006) 1.59
Change in smoking status after spiral chest computed tomography scan screening. Cancer (2003) 1.55
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2002) 1.55
miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol (2010) 1.54
Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer (2010) 1.53
Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer (2005) 1.51
Assessment of mitotic rate reporting in melanoma. Am J Surg (2012) 1.47
Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes. RNA (2009) 1.45
Enhanced disease susceptibility 1 and salicylic acid act redundantly to regulate resistance gene-mediated signaling. PLoS Genet (2009) 1.44
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.43
Endoscopic evaluation of arytenoid function and epiglottic structure in Thoroughbred yearlings and association with racing performance at two to four years of age: 2,954 cases (1998-2001). J Am Vet Med Assoc (2010) 1.38
Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci U S A (2014) 1.37
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer (2007) 1.36
Gender-related differences in outcome for melanoma patients. Ann Surg (2006) 1.32
Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol (2005) 1.27
A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer (2006) 1.26
Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer (2004) 1.19
Quadratic regression analysis for gene discovery and pattern recognition for non-cyclic short time-course microarray experiments. BMC Bioinformatics (2005) 1.19
Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients. Chest (2007) 1.19
Leptin regulates olfactory-mediated behavior in ob/ob mice. Physiol Behav (2006) 1.17
Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg (2005) 1.17
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest (2007) 1.16
Emx2 stimulates odorant receptor gene expression. Chem Senses (2008) 1.16
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer (2009) 1.15
A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer (2007) 1.14
Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med (2005) 1.13
Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability. Oncogene (2002) 1.12
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study. J Thorac Oncol (2012) 1.12
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg (2012) 1.11
Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med (2005) 1.11
Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg (2005) 1.09
Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol (2009) 1.08
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer. J Clin Oncol (2005) 1.07
Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer. Proteomics (2004) 1.05
Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancer. Clin Cancer Res (2007) 1.05
Individual microRNAs (miRNAs) display distinct mRNA targeting "rules". RNA Biol (2010) 1.04
Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev (2012) 1.04
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res (2005) 1.03
Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusion. J Hepatol (2004) 1.02
Analysis of oligonucleotide array experiments with repeated measures using mixed models. BMC Bioinformatics (2004) 1.01
Statistics and bioinformatics in nutritional sciences: analysis of complex data in the era of systems biology. J Nutr Biochem (2010) 1.00
Linear methods for analysis and quality control of relative expression ratios from quantitative real-time polymerase chain reaction experiments. ScientificWorldJournal (2011) 0.97
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. Ann Surg (2010) 0.96
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer (2007) 0.96
Characterization of the human polymeric immunoglobulin receptor (PIGR) 3'UTR and differential expression of PIGR mRNA during colon tumorigenesis. J Biomed Sci (2003) 0.95
Gene expression patterns specific to the regenerating limb of the Mexican axolotl. Biol Open (2012) 0.95
Coregulated expression of loline alkaloid-biosynthesis genes in Neotyphodium uncinatum cultures. Fungal Genet Biol (2009) 0.95
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc (2008) 0.94
Genomics of mature and immature olfactory sensory neurons. J Comp Neurol (2012) 0.94
Imatinib mesylate-induced interstitial pneumonitis. Mayo Clin Proc (2003) 0.94
Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference. Chest (2005) 0.94
Gene expression profile of mouse white adipose tissue during inflammatory stress: age-dependent upregulation of major procoagulant factors. Aging Cell (2013) 0.93
Temporal profiling of gene expression during neurogenesis and remodeling in the olfactory epithelium at short intervals after target ablation. J Neurosci Res (2005) 0.93
Molecular profiling of ulcerative colitis-associated neoplastic progression. Exp Mol Pathol (2005) 0.93
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. J Thorac Oncol (2008) 0.92
Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg (2011) 0.92
Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett (2004) 0.92
Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detect Prev (2003) 0.92
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer (2005) 0.92
Second primary melanomas: incidence and outcome. Am Surg (2010) 0.92
Transcriptional profiling differences for articular cartilage and repair tissue in equine joint surface lesions. BMC Med Genomics (2009) 0.91
Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis (2007) 0.91
Using common table expressions to build a scalable Boolean query generator for clinical data warehouses. IEEE J Biomed Health Inform (2014) 0.91
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg (2011) 0.90
An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management. Am J Respir Crit Care Med (2015) 0.90
Computed tomographic screening for lung cancer: home run or foul ball? Mayo Clin Proc (2003) 0.90
Plasma PGE-2 levels and altered cytokine profiles in adherent peripheral blood mononuclear cells in non-small cell lung cancer (NSCLC). Mol Cancer (2002) 0.89
Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer. Cancer Biol Ther (2010) 0.89
Age-dependent vulnerability to experimental acute pancreatitis is associated with increased systemic inflammation and thrombosis. Aging Cell (2012) 0.89
Cellular and molecular characterization of oxidative stress in olfactory epithelium of Harlequin mutant mouse. J Neurosci Res (2008) 0.89